YOUNGBLOOD DR KNEELAND 4
4 · Light & Wonder, Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
YOUNGBLOOD DR KNEELAND
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-10+2,093→ 18,664 total - Exercise/Conversion
Common Stock
2023-06-12+1,928→ 20,592 total - Exercise/Conversion
Restricted Stock Units
2023-06-10−2,093→ 2,093 total→ Common Stock (2,093 underlying) - Exercise/Conversion
Restricted Stock Units
2023-06-12−1,928→ 0 total→ Common Stock (1,928 underlying)
Footnotes (2)
- [F1]Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The balance of the award is scheduled to vest on June 10, 2024. Each unit converts into a share of common stock on a one-for-one basis.
- [F2]Represents vesting of one-fourth of restricted stock units granted on June 12, 2019. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.